Beta-blockers are used in chronic open-angle glaucoma and in primary or secondary intraocular hypertension.

Beta-blockers are used in chronic open-angle glaucoma and in primary or secondary intraocular hypertension.

Gastric antisecretory treatment when oral administration is not possible.

* Treatment of severe hypercalcemia of malignant origin.

* Treatment of stage III multiple myeloma with at least one bone lesion.

* Palliative treatment of malignant osteolysis with or without hypercalcemia in addition to specific tumor treatment.

* Treatment of Paget's disease.

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

Piroxicam is indicated for the short-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis. Due to its tolerance profile (see sections 4.2, 4.3, and 4.4), piroxicam should not be used as a first-line treatment when an NSAID is indicated.

The decision to prescribe a medicine containing piroxicam should be based on the assessment of all risks specific to each patient (see sections 4.3 and 4.4).

Piroxicam is indicated for the short-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis. Due to its tolerance profile (see sections 4.2, 4.3, and 4.4), piroxicam should not be used as a first-line treatment when an NSAID is indicated.

The decision to prescribe a medicine containing piroxicam should be based on the assessment of all risks specific to each patient (see sections 4.3 and 4.4).